A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

• Autors principals: Andrew F. Alexis (Autor), Melinda Gooderham (Autor), Shawn G. Kwatra (Autor), Ahmad Amin (Autor), Susan Taylor (Autor), Ramon Espaillat (Autor), Trisha Rettig (Autor), Tianshuang Wu (Autor), Linyu Shi (Autor), Mark I. Kaldas (Autor), Deanne M. Dilley (Autor), Ranjeeta Sinvhal (Autor), Chudy Nduaka (Autor), Benjamin Lockshin (Autor)
• Format: Llibre
• Publicat: Adis, Springer Healthcare, 2024-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label ext...